Shares of Hypera S.A. (OTCMKTS:HYPMY – Get Free Report) hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as $3.19 and last traded at $3.23, with a volume of 5491 shares traded. The stock had previously closed at $3.24.
Hypera Stock Down 0.3 %
The firm has a fifty day moving average price of $4.16 and a 200 day moving average price of $4.90.
About Hypera
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
See Also
- Five stocks we like better than Hypera
- What is Insider Trading? What You Can Learn from Insider Trading
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- What Makes a Stock a Good Dividend Stock?
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- Business Services Stocks Investing
- BlackRock Makes Waves With $12B Private Credit Acquisition
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
